All Sauce from Weekly Sauce:

Access to psychotherapy has increased substantially among Americans, particularly young adults, a new study has found. About 12% of young adults received psychotherapy in 2021, followed by 8% of the middle-aged and 5% of seniors, researchers found. Overall, the percentage of U.S. adults receiving psychotherapy rose from about 7% in 2018 to 9% in 2021,…  read on >  read on >

Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical trial funded by Lilly. “Given the increased interest around obesity medications, we conducted this study to help health care providers and patients make informed decisions about treatment choice,” Dr. Leonard Glass, senior vice president of…  read on >  read on >

About a third of America’s pharmacies have closed since 2010, amounting to an “unprecedented decline” in neighborhood drug stores, a new study finds. The drop began in 2018, primarily driven by store closures among chain pharmacies during a period of consolidation in the industry, researchers found. This has made it much more difficult for people…  read on >  read on >

People who smoke and vape are less able to break free of their nicotine addiction than folks who only have one of those habits, a new review concludes. Instead, these “dual users” are more likely to eventually drop vaping and continue smoking tobacco, results show. The findings point to the insidious pull of nicotine and…  read on >  read on >

Taking even high doses of supplementary vitamin D won’t lower an older person’s odds for type 2 diabetes, new research confirms. Vitamin D supplements may have other benefits, but in otherwise healthy folks with sufficient levels of the nutrient, “our findings do not suggest benefits of long-term moderate- or high-dose vitamin D3 supplementation” in warding off…  read on >  read on >